Articles with category: Article
Nangs - what you need to know
Everything you need to know about nitrous oxide use in New Zealand
Have your say on New Zealand's Mental Health & Wellbeing Strategy
The Ministry of Health is asking for feedback on the draft Mental Health and Wellbeing Strategy.
Roadside drug testing: what you need to know
Random roadside saliva tests are rolling out from December 2025.
Charting fifty years of failure
50 years after it was passed into law, journalist Russell Brown plots a potted history of the Misuse of Drugs Act 1975
On the frontlines of the methamphetamine surge
A doubling of methamphetamine use has left under-resourced community organisations struggling to respond
What researchers at University of Auckland are learning from giving people microdoses of LSD
‘Microdosing’ psychedelics involves taking small, repeated doses of a psychedelic drug. Researcher Robin Murphy talks us through the latest Auckland University microdosing study.
Beyond the bottle: Paddy, Guyon, and Lotta on life after alcohol
Well-known NZers share what it's like to live without alcohol in a culture that celebrates it at every turn
Reflections from the 2024 UN Commission on Narcotic Drugs
Executive Director Sarah Helm reflects on this year's global drug conference
What can we learn from Australia’s free naloxone scheme?
As harm reduction advocates in Aotearoa push for better naloxone access, we look for lessons across the ditch.
Could regulating MDMA make it safer?
Given MDMA’s popularity, potential therapeutic uses, and low harm profile, is it time we re-examine how we regulate it here? Drug Foundation Senior Communications Advisor Feilidh Dwyer investigates.
A Psychedelic Renaissance? 'Blue Honey' and what's next for psilocybin in Aotearoa
In Aotearoa, scientists, iwi, as well as hobbyists and amateurs are busy researching what psilocybin’s potential could be. So, what’s next for psilocybin in Aotearoa?
What Australia's surprise MDMA and psilocybin move means
Russell Brown takes a look at how Australia's recent move to allow psilocybin and MDMA for prescription would work in practice, and whether a similar shift could be possible in New Zealand.